ACTRN12608000583347已完成3 期
A randomised controlled trial of a fixed dose combination medication (Polypill) versus usual care for improved adherence to indicated pharmacotherapy among Indigenous and Non-Indigenous people at high risk of a cardiovascular event.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Adults aged 18 years and older, 2. Participant is able to give informed consent, 3. High cardiovascular risk defined by: history of coronary heart disease, history of ischaemic cerebrovascular disease, history of peripheral vascular disease or calculated 5 year cardiovascular disease (CVD) risk or greater using the 1991 Anderson Framingham risk equation with adjustments as defined by the National Heart Foundation (NHF) Hypertension guidelines. 4. The responsible clinician believes each of the polypill components are indicated and can be prescribed under the Pharmaceutical Benefits Scheme (PBS), 5.The responsible clinician is unsure as to whether a polypill based strategy or usual care is better. 6. Additionally, Aboriginal and/or Torres Strait Islander participants should have their status recorded by the participating health service and confirmed by self-identification.
排除标准
- •1. Contraindication to any components of the polypill, 2. the responsible clinician feels change to current therapy will place a patient at risk.
研究者
相似试验
终止
3 期
Guidelines Adherence to the Polypill Study. A clinical trial of a fixed dose combination medication (Polypill) versus usual care for improved adherence to indicated pharmacotherapy among individuals at high risk of a cardiovascular event.Cardiovascular diseaseACTRN12608000584336The George Institute for International Health1,000
已完成
3 期
MPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events.The study is a Clinical Trial that will compare the polypill (a single capsule containing aspirin, a statin [cholesterol lowering medicine], and two blood pressure lowering medicines) to the usual medicines that you take to help prevent heart attack and stroke.CTRI/2010/091/000250Imperial College London2,000
进行中（未招募）
1 期
A randomised placebo-controlled trial of fixed-dose combination medication in those at raised risk of cardiovascular disease - PILL PilotCardiovascular DiseaseEUCTR2007-002466-35-GBImperial Ciollege600
进行中（未招募）
1 期
A randomised placebo-controlled trial of fixed-dose combination medication in those at raised risk of cardiovascular disease - PILL PilotMedDRA version: 9.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedCardiovascular DiseaseEUCTR2007-002466-35-NLImperial Ciollege378
已完成
3 期
A randomized controlled trial for low-dose continuous Infusion of human atrial natriuretic peptide for cardiac dysfunction undergoing cardiac surgerymyocardial infarction, anginaJPRN-UMIN000001652ihon University School of Medicine130